Fortress Biotech, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Fortress Biotech, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2012 to Q3 2024.
  • Fortress Biotech, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $3.35M, a 30.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.35M -$1.48M -30.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $3.36M -$216K -6.05% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.97M +$3.03M +321% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.28M +$3.31M +340% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $4.82M +$3.43M +246% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.57M +$2.41M +206% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $943K -$129K -12% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $973K -$225K -18.8% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.39M -$314K -18.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.17M +$41K +3.64% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.07M -$49K -4.37% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.2M +$185K +18.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.71M +$352K +26% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.13M -$224K -16.6% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1.12M -$232K -17.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $1.01M -$145K -12.5% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $1.36M +$177K +15% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.35M +$113K +9.14% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.35M +$128K +10.4% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.16M +$882K +320% Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $1.18M +$358K +43.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.24M +$271K +28.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.23M +$289K +30.9% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $276K +$18K +6.98% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $821K +$475K +137% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $966K +$570K +144% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $936K +$546K +140% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $258K -$136K -34.5% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $346K +$298K +621% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $396K +$352K +800% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $390K +$14K +3.72% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $394K +$351K +816% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $48K -$146K -75.3% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $44K -$128K -74.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $376K -$635K -62.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $43K -$21K -32.8% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $194K +$13K +7.18% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $172K +$103K +149% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.01M +$941K +1344% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $64K -$40K -38.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 $181K +$72K +66.1% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $69K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $70K Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $104K -$245K -70.2% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $109K Sep 30, 2013 10-Q 2013-11-01
Q4 2012 $349K Dec 31, 2012 10-K 2014-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.